AI and DTB, drug safety, tirzepatide, and lecanemab for Alzheimer's disease

DTB podcast by BMJ Group

In this podcast accompanying the August issue of DTB ( ), David Phizackerley (DTB Editor) is joined by James Cave (former DTB Editor-in-Chief). David and James discuss an editorial generated by artificial intelligence (A...View more